Doctor Donato Cappetta
Second University of Naples, Naples (Italy)
Dapagliflozin improves diastolic performance in an animal model of heart failure with preserved ejection fraction
Event: Heart Failure 2019
Topic: Ion Channels, Electrophysiology
Session: Basic Science - HFpEF and Pulmonary Hypertension
Dipeptidyl peptidase 4 inhibitor sitagliptin ameliorates renal function in a model of hypertension-induced cardiorenal disease
Event: Heart Failure 2018
Topic: Cardiac Diseases
Session: Basic Science - Cardiac Diseases
Dipeptidyl peptidase 4 inhibitor sitagliptin ameliorates cardio-renal axis in Dahl salt-sensitive hypertensive rat model
Event: Frontiers in CardioVascular Biology 2018
Topic: Heart Failure
Session: LBS Poster Session 2
Effects of SGLT2 inhibitor dapagliflozin in a non-diabetic hypertensive model of heart failure with preserved ejection fraction
Event: Frontiers in CardioVascular Biology 2018
Topic: Heart Failure
Session: LBS Poster Session 2
Resveratrol attenuates diastolic dysfunction by reducing cardiac fibrosis in a model of doxorubicin cardiomyopathy
Event: HEART FAILURE 2016
Topic: Cardiomyopathies
Session: Basic Science: Cardiomyopathy
ESC 365 is supported by
